Related Experiment Video

Updated: May 4, 2026

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
13:13

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

29.2K

Myocardial cardiotrophin-1 is differentially induced in congenital cardiac defects depending on hypoxemia

Ruth Heying1, Ma Qing, Katharina Schumacher

  • 1Department of Pediatric Cardiology, Aachen University, Aachen, Germany.

Future Cardiology
|December 19, 2013
PubMed

Insights

Cardiotrophin-1 (CT-1) levels in infants with congenital heart defects correlate with hypoxemia. Higher CT-1 expression in Tetralogy of Fallot patients suggests a role in myocardial hypertrophy and dysfunction.

Area of Science:

  • Pediatric Cardiology
  • Molecular Cardiology
  • Neonatal Research

Background:

  • Cardiotrophin-1 (CT-1) is a cytokine known for its hypertrophic and protective effects on cardiac cells.
  • CT-1 expression is influenced by conditions like hypoxemia and hemodynamic overload.
  • Congenital cardiac defects in infants often involve altered oxygen levels and cardiac stress.

Purpose of the Study:

  • To investigate the differential induction of CT-1 in the myocardium of infants with congenital cardiac defects.
  • To determine if CT-1 levels are influenced by the degree of hypoxemia in these infants.

Main Methods:

  • Studied infants with Tetralogy of Fallot and large ventricular septal defects undergoing surgery.
  • Assessed CT-1 mRNA and protein expression in myocardial tissue.
  • Measured STAT-3 and VEGF activation, and cardiac troponin-I degradation as a marker of damage.

Main Results:

  • CT-1 was detected in all infants, with levels inversely correlating to arterial oxygen saturation.
  • Tetralogy of Fallot patients exhibited higher CT-1 expression.
  • Higher CT-1 correlated with JAK/STAT pathway activation and increased cardiac troponin-I degradation.

Conclusions:

  • CT-1 may play a role in mediating myocardial hypertrophy and dysfunction in infants with congenital heart defects.
  • Hypoxemia appears to be a significant factor in CT-1 induction in this population.
  • CT-1's involvement suggests potential therapeutic targets for hypoxemia-related cardiac issues.
Abstract

More Related Videos

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer11:26

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer

Published on: February 13, 2019

8.3K
Isolation and Physiological Analysis of Mouse Cardiomyocytes11:02

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

22.9K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.2K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952